Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Julie Frund's research focuses on understanding the clinical characteristics and outcomes of drug-induced liver injury, particularly associated with amoxicillin/clavulanate. Her work utilizes large-scale electronic health record data to identify patient phenotypes and assess injury frequency. A recent publication examined 1.4 million patients within the Veterans Health Administration, characterizing acute liver injury related to amoxicillin/clavulanate and its associated outcomes. Frund has collaborated with Weida Tong of the National Center for Toxicological Research and Fred Prior at the University of Arkansas for Medical Sciences on shared publications. Her scholarship metrics include an h-index of 2 and 2 total publications with 19 citations.
Metrics
- h-index: 2
- Publications: 2
- Citations: 19
Selected Publications
-
Assessment of the Frequency, Phenotypes, and Outcomes of Acute Liver Injury Associated with Amoxicillin/Clavulanate in 1.4 Million Patients in the Veterans Health Administration (2022)
-
Near Real Time EHR Data Utilization in a Clinical Study (2020)
Collaboration Network
Top Collaborators
- Assessment of the Frequency, Phenotypes, and Outcomes of Acute Liver Injury Associated with Amoxicillin/Clavulanate in 1.4 Million Patients in the Veterans Health Administration
- Assessment of the Frequency, Phenotypes, and Outcomes of Acute Liver Injury Associated with Amoxicillin/Clavulanate in 1.4 Million Patients in the Veterans Health Administration
- Assessment of the Frequency, Phenotypes, and Outcomes of Acute Liver Injury Associated with Amoxicillin/Clavulanate in 1.4 Million Patients in the Veterans Health Administration
- Assessment of the Frequency, Phenotypes, and Outcomes of Acute Liver Injury Associated with Amoxicillin/Clavulanate in 1.4 Million Patients in the Veterans Health Administration
- Assessment of the Frequency, Phenotypes, and Outcomes of Acute Liver Injury Associated with Amoxicillin/Clavulanate in 1.4 Million Patients in the Veterans Health Administration
- Assessment of the Frequency, Phenotypes, and Outcomes of Acute Liver Injury Associated with Amoxicillin/Clavulanate in 1.4 Million Patients in the Veterans Health Administration
- Assessment of the Frequency, Phenotypes, and Outcomes of Acute Liver Injury Associated with Amoxicillin/Clavulanate in 1.4 Million Patients in the Veterans Health Administration
- Assessment of the Frequency, Phenotypes, and Outcomes of Acute Liver Injury Associated with Amoxicillin/Clavulanate in 1.4 Million Patients in the Veterans Health Administration
- Assessment of the Frequency, Phenotypes, and Outcomes of Acute Liver Injury Associated with Amoxicillin/Clavulanate in 1.4 Million Patients in the Veterans Health Administration
- Assessment of the Frequency, Phenotypes, and Outcomes of Acute Liver Injury Associated with Amoxicillin/Clavulanate in 1.4 Million Patients in the Veterans Health Administration
- Assessment of the Frequency, Phenotypes, and Outcomes of Acute Liver Injury Associated with Amoxicillin/Clavulanate in 1.4 Million Patients in the Veterans Health Administration
Similar Researchers
Based on overlapping research topics